Labshake search
Citations for Tocris :
1 - 50 of 1069 citations for Cow G Protein Coupled Bile Acid Receptor 1 GPBAR1 ELISA Kit since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2022Quote: ... the AMPA/NMDA receptor agonist kynurenic acid (2 mM) and the GABA-A receptor antagonist picrotoxin (PTX; 100 uM, Tocris) were present ...
-
bioRxiv - Neuroscience 2020Quote: ... and the glutamate receptor antagonist kynurenic acid (3 mM KynA, Tocris Bioscience) was included in the external solution to isolate GABA currents ...
-
bioRxiv - Neuroscience 2022Quote: ... and the selective NMDA receptor antagonist amino-5-phosphonopentanoic acid (AP5; 50 μM, Tocris).
-
bioRxiv - Neuroscience 2022Quote: ... and L-2-amino-5-phosphonopentanoic acid (APV, an NMDA receptor blocker) from Tocris. APV ...
-
bioRxiv - Neuroscience 2023Quote: ... and 10 μM 6-Imino-3-(4-methoxyphenyl)-1(6H)-pyridazinebutanoic acid hydrobromide (SR95531; GABAA receptor antagonist, all from Tocris). The resting membrane potential was measured after whole-cell configuration was achieved ...
-
bioRxiv - Cell Biology 2021Quote: ... B/D medium was supplemented during submerged culture with 1 nM EC23 (light-stable retinoic acid receptor agonist; Tocris, Abingdon, UK). After confluence was reached ...
-
bioRxiv - Neuroscience 2023Quote: ... and 10 µM 6-imino-3-(4-methoxyphenyl)-1(6H)-pyridazinebutanoic acid hydrobromide (SR95531;GABAA receptor antagonist; all from Tocris Bioscience).
-
bioRxiv - Neuroscience 2024Quote: ... BIBP-3226 (Y1 receptor antagonist, 1-2 μM), and BIIE-0246 (Y2 receptor antagonist, 1-2 μM) were obtained from Tocris.
-
bioRxiv - Neuroscience 2022Quote: ... to block ionotropic gamma-amino-butyric acid receptors (GABAARs) and 10 μM NBQX (1044, Tocris Biosciences) to inhibit α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) ...
-
bioRxiv - Developmental Biology 2021Quote: ... the BMP type-I receptor inhibitor DMH-1 (1 μM, Tocris) and ROCK inhibitor Y-27632 2HCl (10 μM) ...
-
bioRxiv - Cancer Biology 2022Quote: ... the BMP type-I receptor inhibitor DMH-1 (1 μM, Tocris) and ROCK inhibitor Y-27632 2HCl (10 μM) ...
-
Sexual differences in neuronal and synaptic properties across subregions of the mouse insular cortexbioRxiv - Neuroscience 2023Quote: ... and L-APV 50 μM (DL-2-Amino-5-phosphonopentanoic acid, a selective NMDA receptor antagonist, Tocris).
-
bioRxiv - Neuroscience 2020Quote: ... The bath solution for recordings contained elevated concentrations of divalent cations [4 mM Ca2+ and 4 mM Mg2+] and NMDA receptor antagonist 3-(2-Carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) [5 mM] (Tocris biosciences, 126453-07-4). Slices were used 1.5–4.5 hours after preparation ...
-
bioRxiv - Cancer Biology 2022Quote: ... the BMP type-I receptor inhibitor DMH-1 (1 μM, Cat# 4126, Tocris), 10 μM of Rock Inhibitor (Y-27632 ...
-
bioRxiv - Neuroscience 2019Quote: ... To block NMDA receptors we used D- (-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris, 10 μM final concentration). To block glycinergic inhibition ...
-
bioRxiv - Neuroscience 2021Quote: ... To interfere with group I metabotropic glutamate receptor (mGluR) signaling we used bath application of either the mGlu1 receptor antagonist YM298198 (1 μM, Tocris, Germany) or the mGluR5 receptor antagonist MPEP (10 μM ...
-
bioRxiv - Cell Biology 2021Quote: Receptors were stimulated as follows: human Angiotensin 1 receptor (AT1R) with Angiotensin II (AngII; Tocris 4474-91-3, in measuring buffer), human β2 adrenergic receptor (β2ADR ...
-
bioRxiv - Neuroscience 2019Quote: ... glycine receptors (GlyR) and GABAB receptors 10 μM (−)Bicuculline methiodide (Tocris Bioscience), 2 μM Strychnine hydrochloride (Tocris Bioscience ...
-
bioRxiv - Biochemistry 2023Quote: ... 500 nM A83-01 TGF-ß type 1 receptor inhibitor (Tocris) and 10 µM SB202190 P38 MAPK inhibitor (Sigma-Aldrich) ...
-
bioRxiv - Neuroscience 2021Quote: ... synaptic GABA currents were recorded in perfusing aCSF containing the glutamate receptor antagonist kynurenic acid (3 mM, Tocris, Ellisville, MO). Recorded neurons were initially held at −70 mV for interneurons and −60 mV for GCs and SGCs and the response to 500 milli-second positive and negative current injections were examined to determine active and passive characteristics ...
-
bioRxiv - Neuroscience 2021Quote: ... Glutamatergic neurons were identified by their characteristic EPSC time course and by sensitivity of EPSC to application of glutamate receptor antagonist kynurenic acid (Tocris). Synaptic currents were acquired at 10 kHz using pClamp 10.2 software (Molecular Devices ...
-
bioRxiv - Neuroscience 2020Quote: ... and the NMDA receptor open-channel blocker MK-801 (Tocris, 1 mM) in the recording pipette solution ...
-
bioRxiv - Cell Biology 2021Quote: ... interleukin-1 receptor-associated kinase 1 and 4 (IRAK 1/4; IRAK 1/4 inhibitor, 0.1 μM; Tocris); TANK-binding kinase 1 (TBK1 ...
-
bioRxiv - Neuroscience 2021Quote: ... The bath solution usually contained 6,7-dinitroquinoxaline-2,3-dione (DNQX, 10 µM) and D- aminophosphonovaleric acid (D-APV, 50 µM) to block ionotropic glutamate receptors (Tocris, Abingdon, United Kingdom). Patch electrodes had resistances of 4-6 MΩ when filled with KMeSO4- or CMeSO4-based internal solution (same as used in vivo) ...
-
bioRxiv - Neuroscience 2020Quote: ... co-applied with the competitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid AMPA/kainate receptor antagonist CNQX (Tocris; 20 μM) (n=13) ...
-
bioRxiv - Cell Biology 2020Quote: ... or blockers of receptors associated with OxPC activity including platelet activating factor receptor (WEB-2086, Tocris 2339), prostaglandin EP2 receptor (PF-04418948 ...
-
bioRxiv - Cell Biology 2020Quote: ... prostaglandin EP2 receptor (PF-04418948, Tocris 4814), CD36 [sulfosuccinimidyl oleate (SSO) ...
-
bioRxiv - Immunology 2019Quote: ... Adenosine receptor drugs were purchased from Tocris or Sigma Aldrich ...
-
bioRxiv - Immunology 2021Quote: ... and AT1 receptor antagonist Candesartan cilexetil (Tocris) were used in this study ...
-
bioRxiv - Immunology 2022Quote: ... the CCR3 receptor antagonist SB328437 (Tocris Bioscience) was added at a final concentration of 10 μM (41) ...
-
bioRxiv - Neuroscience 2023Quote: ... GABAB receptor antagonist CGP55845 (3 μM, Tocris), Na+ channel blocker tetrodotoxin (TTX ...
-
bioRxiv - Biochemistry 2023Quote: ... SKF81297 hydrobromide (D1-like receptor agonist, TOCRIS), quinpirole hydrochloride (D2-like receptor agonist ...
-
bioRxiv - Biochemistry 2023Quote: ... SCH 39166 (D1-like receptor antagonist, TOCRIS), raclopride (D2-like receptor antagonist ...
-
bioRxiv - Biochemistry 2023Quote: ... quinpirole hydrochloride (D2-like receptor agonist, TOCRIS), SCH 39166 (D1-like receptor antagonist ...
-
bioRxiv - Neuroscience 2019Quote: ... The receptor-selective agonists we used included SKF 81297 for D1-like receptors (10–50 µM; Tocris, Minneapolis, MN); quinpirole for D2-like receptors (10–50 µM ...
-
bioRxiv - Neuroscience 2020Quote: ... N-methyl D-aspartate (NMDA) receptors were blocked by the non-competitive NMDA receptor antagonist MK-801 (Tocris; 100 μM), co-applied with the competitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid AMPA/kainate receptor antagonist CNQX (Tocris ...
-
bioRxiv - Developmental Biology 2020Quote: ... and TGFβ Receptor I Inhibitor II (25nM; Tocris were also used in this study ...
-
bioRxiv - Neuroscience 2020Quote: ... NMDA receptor blockers (D-AP5 50 μM, Tocris; (+)MK-801 10 μM ...
-
bioRxiv - Neuroscience 2021Quote: The Cck1 receptor (Cck1R) agonist A71623 (Tocris Biosciences) was suspended in 20mM PBS according to the manufacturer’s directions ...
-
bioRxiv - Neuroscience 2022Quote: ... the AMPA receptor blocker DNQX (10 mM, Tocris) was applied to the cortical surface in a subset of experiments ...
-
bioRxiv - Neuroscience 2023Quote: The general dopamine receptor antagonist flupenthixol dihydrochloride (Tocris) was prepared at a concentration of 100 μM in sterile 0.9% saline and frozen in aliquots that were thawed fresh immediately prior to use ...
-
bioRxiv - Neuroscience 2023Quote: ... and 50 μM NMDA receptor antagonist AP5 (Tocris). Data were filtered at 4 kHz and digitized at 20 kHz using Digidata 1550B and Clampex software (Molecular Devices) ...
-
bioRxiv - Neuroscience 2023Quote: ... AMPA receptor antagonist NBQX (20 μM, Tocris, 0373) and NMDA receptor antagonist APV (50 μM ...
-
bioRxiv - Immunology 2023Quote: ... AP-5 (25 nM, NMDA receptor blocker, Tocris), and actinomycin D (RNA polymerase inhibitor ...
-
bioRxiv - Neuroscience 2023Quote: ... The dopamine D2-receptor antagonist raclopride (Tocris Bioscience) was used at a concentration of 100 μM ...
-
bioRxiv - Neuroscience 2023Quote: ... CNQX (10 μM, Tocris; an AMPA receptor antagonist), glycine (10 μM ...
-
bioRxiv - Neuroscience 2024Quote: Oxytocin receptor antagonist (OTRA; L-368,899; Tocris 2641) was dissolved in saline 95% and DMSO 5% ...
-
bioRxiv - Neuroscience 2020Quote: ... Substance P was manipulated by injecting the agonist of the NK-1 receptor Substance P (Tocris) to an estimated final concentration of 200 nM ...
-
bioRxiv - Neuroscience 2021Quote: ... 3-((±)2-carboxypiperazin-4yl) propyl-1-phosphate (CPP, NMDA receptor antagonist, 20 μM; Tocris Bioscience, UK) and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX ...
-
bioRxiv - Neuroscience 2021Quote: ... or kainic acid (Tocris, 1 μM; Tocris 0222) were bath-applied sequentially (ensuring that holding current returned to the original control level before subsequent drug application ...